• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    More On HIK.L

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    Hikma Pharmaceuticals plc (HIK.L)

    -LSE
    2,032.00 Down 11.00(0.54%) Dec 19, 11:35AM EST
    Add to Portfolio
    Prev Close:2,043.00
    Open:2,053.00
    Bid:2,031.00
    Ask:2,033.00
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:2,002.00 - 2,053.00
    52wk Range:1,174.00 - 2,065.00
    Volume:306,843
    Avg Vol (3m):330,499
    Market Cap:4.02B
    P/E (ttm):1,312.66
    EPS (ttm):1.55
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in GBp.

    Key Statistics

    Forward P/E (1 yr):15.16
    P/S (ttm):276.12
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :1.40
    Quarterly EPS Est (Dec-14) :N/A
    Mean Recommendation*:2.7
    PEG Ratio (5 yr expected):1.36

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Hikma Pharmaceuticals PLC develops, manufactures, and markets a range of generic and in-licensed pharmaceutical products in solid, semi-solid, liquid, and injectable final dosage forms in the Middle East and North Africa, the United States, and Eu... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback